Results - Why Nozin is #1
Nozin Programs powered by Nozin
®
Nasal Sanitizer
®
have proven to outperform traditional products
and protocols. Outcomes recently presented or
published include:
• 98% MRSA infection rate reduction
1
• Up to 60% reduction in PPE use
2
• $1,394,685 cost savings
3
• 74% reduction in nasal PCR tests
3
15 years of safe, effective use.
Patented Nozaseptin
®
formula has helped protect
millions of patients and staff. Delivery and
application system designed specifically for daily
nasal use. Patient and staff preferred.
Small Tool. Big Results.
#1 in daily patient nasal decolonization.
1. Stegmeier H. Alcohol-Based Nasal Antiseptic as Part of a Bundle to Reduce the Incidence of Contact Precautions and Surgical Site Infections. Open Forum Infect Dis. 2019 Oct; 6 (Suppl
2): S446. 2. Arden S. Does Universal Nasal Decolonization with an Alcohol-Based Nasal Antiseptic Reduce Infection Risk and Cost? Open Forum Infect Dis 2019 Oct; 6(Suppl 2): S26. 3.
Whitaker J. et al. A Safe, More Cost-Effective Protocol: Universal Decolonization vs. MRSA Screening and Contact Precautions. Open Forum Infect Dis. 2019 Oct; 6(Suppl 2): S25. Outcomes
reported by actual users. Your results may vary. Nozin
®
Nasal Sanitizer
®
antiseptic is for nasal decolonization. ©2020 Global Life Technologies Corp. All rights reserved. Made in USA. Nozin
®
,
Nasal Sanitizer
®
, Popswab
®
and Nozaseptin
®
are trademarks of Global Life Technologies Corp. Nozin
®
Nasal Sanitizer
®
antiseptic is an OTC topical drug. No claim is made that it has an effect
on any specific disease. Nozin Patents: No. 8,778,415; No. 8,158,163; No. 7,638,147; No. 8,999,406; No. 9,463,212; No. 9,943,561; No. 10,307,452.
Find out why so many facilities are adopting our MRSA/MSSA Risk Mitigation Programs,
powered by Nozin
®
Nasal Sanitizer
®
antiseptic.
Contact us at: 877-669-4648 or send us a note at professionalservices@nozin.com
Ask for a Nozin MRSA risk mitigation analysis for your facility.
Nozin® Nasal Sanitizer ® antiseptic
Popswab® ampule actual size.
